# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-000346
Filing Date
2023-01-04
Accepted
2023-01-04 16:59:57
Documents
62
Period of Report
2022-10-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 1257277
2 |  | ex23-1.htm | EX-23.1 | 4403
3 |  | ex31-1.htm | EX-31.1 | 16678
4 |  | ex31-2.htm | EX-31.2 | 17306
5 |  | ex32-1.htm | EX-32.1 | 7090
6 |  | ex32-2.htm | EX-32.2 | 7473
| Complete submission text file | 0001493152-23-000346.txt |  | 6025018

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | anix-20221031.xsd | EX-101.SCH | 36350
8 | INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | anix-20221031_cal.xml | EX-101.CAL | 46751
9 | INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | anix-20221031_def.xml | EX-101.DEF | 172136
10 | INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | anix-20221031_lab.xml | EX-101.LAB | 355932
11 | INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | anix-20221031_pre.xml | EX-101.PRE | 270279
56 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 1033814

Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-37492 | Film No.: 23507554
SIC: 2834 Pharmaceutical Preparations